SEC Form FWP filed by Carlyle Credit Income Fund Shares of Beneficial Interest
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated October 23, 2025
Relating to Preliminary Prospectus Supplement dated October 23, 2025 and
Prospectus dated September 29, 2023
Registration No. 333-272426
Carlyle Credit Income Fund
7.375% Series D Preferred Shares Due 2028
(Liquidation Preference $25.00 per share)
Pricing Term Sheet
October 23, 2025
The following sets forth the final terms of the 7.375% Series D Preferred Shares Due 2028 (the “Shares”) and should only be read together with the preliminary prospectus supplement, dated October 23, 2025, together with the accompanying prospectus dated September 29, 2023, relating to these securities (together, the “Preliminary Prospectus”) and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. In all other respects, this pricing term sheet is qualified in its entirety by reference to the Preliminary Prospectus. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus. All references to dollar amounts are references to U.S. dollars.
| Issuer: | Carlyle Credit Income Fund | |
| Title of the Securities: | 7.375% Series D Preferred Shares Due 2028 (the “Series D Preferred Shares”) | |
| Rating*: | Egan-Jones Ratings Company: BBB+ | |
| Initial Number of Shares Being Offered: | 1,200,000 | |
| Option: | The underwriters may purchase from the Issuer up to an additional 180,000 Shares, within 30 days. | |
| Initial Public Offering Price: | $25.00 liquidation preference per Share; $30,000,000 in aggregate liquidation preference (assuming the underwriters’ option is not exercised) | |
| Underwriting Discount: | $0.50 per Share; $600,000 total (assuming the underwriters’ option is not exercised) | |
| Net Proceeds to the Issuer, before Expenses: | $24.50 per Share; $29,400,000 total (assuming the underwriters’ option is not exercised); $33,810,000 total (if the underwriters’ option is exercised in full) | |
| Trade Date: | October 23, 2025 | |
| Original Issue Date: | October 30, 2025 (T + 5) | |
| Term Redemption Date: | October 30, 2028 | |
| Dividend Rate: | 7.375% per annum | |
| Dividend Payment Date: | Dividends will be payable monthly in arrears on the last business day of every month. | |
| Dividend Period: | The initial dividend period for the Series D Preferred Shares will be the period from October 30, 2025, to, but excluding, December 1, 2025. The subsequent dividend periods will be the period from and including a dividend payment date to, but excluding, the next dividend payment date or the stated maturity, as the case may be. | |
| Regular Record Dates for Dividend: | The record date for the initial dividend period will be November 10, 2025. Dividends with respect to any monthly dividend period will be declared and paid to holders of record of Series D Preferred Shares as their names appear on the registration books at the close of business on the applicable record date, which will be a date designated by the board of trustees that is not more than twenty (20) nor less than seven (7) calendar days prior to the applicable dividend payment date. | |
| Business Days: | Each Monday, Tuesday, Wednesday, Thursday and Friday on which the New York Stock Exchange (“NYSE”) is open for trading. | |
| Optional Redemption: | The Series D Preferred Shares may be redeemed at any time on or after October 30, 2026, in the Issuer’s sole option, in whole or, from time to time, in part, out of funds legally available for such redemption, at the Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if any, on such Shares (whether or not earned or declared, but excluding interest on such dividends) to, but excluding, the date fixed for such redemption. | |
| Listing: | The Issuer intends to list the Shares on the NYSE and expects trading to begin within 30 days of the original issue date under the trading symbol “CCID.” | |
| CUSIP / ISIN: | 92535C 609 / US92535C6093 | |
| Lead Bookrunner: | Lucid Capital Markets, LLC | |
| Joint Bookrunners: | B. Riley Securities, Inc. and Piper Sandler & Co. | |
| Lead Manager: | A.G.P. / Alliance Global Partners | |
| Co-Managers: | Clear Street LLC and InspereX LLC | |
| Transfer Agent: | Equiniti Trust Company, LLC | |
| * | Note: Egan-Jones Ratings Company is a nationally recognized statistical rating organization (NRSRO). A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
The Issuer expects that delivery of the Shares will be made against payment therefor on or about October 30, 2025, which will be the fifth business day following the date of the pricing of the Shares (such settlement being herein referred to as “T+5”). Under Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Shares prior to the date of delivery hereunder will be required, by virtue of the fact that the Shares initially will settle in T+5 business days, to specify an alternative settlement arrangement at the time of any such trade to prevent a failed settlement.
Investors should consider the Issuer’s investment objectives, risks, charges and expenses carefully before investing. The Preliminary Prospectus, which has been filed with the Securities and Exchange Commission (“SEC”), contains this and other information about the Issuer and the Shares and should be read carefully before investing. The information in the Preliminary Prospectus and in this pricing term sheet is not complete and may be changed. The Preliminary Prospectus and this pricing term sheet are not offers to sell securities and are not soliciting offers to buy securities in any jurisdiction where the offer or sale is not permitted or would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
A shelf registration statement relating to these securities is on file with and has been declared effective by the SEC. Before you invest, you should read the Preliminary Prospectus and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. The offering may be made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained by writing Lucid Capital Markets, LLC, at 570 Lexington Avenue, 40th Floor, New York, New York 10022, by calling toll-free 1-646-362-0256 or by sending an e-mail to: [email protected]; copies may also be obtained for free by visiting EDGAR on the SEC’s website at http://www.sec.gov.